518 related articles for article (PubMed ID: 12935294)
21. Negative regulation of myeloid cell proliferation and function by the SH2 domain-containing tyrosine phosphatase-1.
Dong Q; Siminovitch KA; Fialkow L; Fukushima T; Downey GP
J Immunol; 1999 Mar; 162(6):3220-30. PubMed ID: 10092773
[TBL] [Abstract][Full Text] [Related]
22. Interaction of the tyrosine phosphatase SHP-2 with Gab2 regulates Rho-dependent activation of the c-fos serum response element by interleukin-2.
Arnaud M; Mzali R; Gesbert F; Crouin C; Guenzi C; Vermot-Desroches C; Wijdenes J; Courtois G; Bernard O; Bertoglio J
Biochem J; 2004 Sep; 382(Pt 2):545-56. PubMed ID: 15170389
[TBL] [Abstract][Full Text] [Related]
23. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction.
Newton-Nash DK; Newman PJ
J Immunol; 1999 Jul; 163(2):682-8. PubMed ID: 10395658
[TBL] [Abstract][Full Text] [Related]
24. The Shp-2 tyrosine phosphatase activates the Src tyrosine kinase by a non-enzymatic mechanism.
Walter AO; Peng ZY; Cartwright CA
Oncogene; 1999 Mar; 18(11):1911-20. PubMed ID: 10208413
[TBL] [Abstract][Full Text] [Related]
25. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
26. Effects of a leukemia-associated gain-of-function mutation of SHP-2 phosphatase on interleukin-3 signaling.
Yu WM; Daino H; Chen J; Bunting KD; Qu CK
J Biol Chem; 2006 Mar; 281(9):5426-34. PubMed ID: 16371368
[TBL] [Abstract][Full Text] [Related]
27. SHP-1 dephosphorylates 3BP2 and potentially downregulates 3BP2-mediated T cell antigen receptor signaling.
Yu Z; Maoui M; Zhao ZJ; Li Y; Shen SH
FEBS J; 2006 May; 273(10):2195-205. PubMed ID: 16649996
[TBL] [Abstract][Full Text] [Related]
28. Experimental regulation of STAT gene expression reveals an involvement of STAT5 in interleukin-4-driven cell proliferation.
Friedrich K; Wietek S
Biol Chem; 2001 Feb; 382(2):343-51. PubMed ID: 11308032
[TBL] [Abstract][Full Text] [Related]
29. Shp-2 has a positive regulatory role in ES cell differentiation and proliferation.
Qu CK; Feng GS
Oncogene; 1998 Jul; 17(4):433-9. PubMed ID: 9696036
[TBL] [Abstract][Full Text] [Related]
30. The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation.
Adachi T; Flaswinkel H; Yakura H; Reth M; Tsubata T
J Immunol; 1998 May; 160(10):4662-5. PubMed ID: 9590210
[TBL] [Abstract][Full Text] [Related]
31. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway.
Hanafusa H; Torii S; Yasunaga T; Nishida E
Nat Cell Biol; 2002 Nov; 4(11):850-8. PubMed ID: 12402043
[TBL] [Abstract][Full Text] [Related]
32. src homology 2 domain-containing tyrosine phosphatase SHP-1 controls the development of allergic airway inflammation.
Kamata T; Yamashita M; Kimura M; Murata K; Inami M; Shimizu C; Sugaya K; Wang CR; Taniguchi M; Nakayama T
J Clin Invest; 2003 Jan; 111(1):109-19. PubMed ID: 12511594
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of tumor necrosis factor-[alpha]-induced SHP-2 phosphatase activity by shear stress: a mechanism to reduce endothelial inflammation.
Lerner-Marmarosh N; Yoshizumi M; Che W; Surapisitchat J; Kawakatsu H; Akaike M; Ding B; Huang Q; Yan C; Berk BC; Abe J
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1775-81. PubMed ID: 12947019
[TBL] [Abstract][Full Text] [Related]
34. A negative role of SHP-2 tyrosine phosphatase in growth factor-dependent hematopoietic cell survival.
Chen J; Yu WM; Bunting KD; Qu CK
Oncogene; 2004 Apr; 23(20):3659-69. PubMed ID: 15116097
[TBL] [Abstract][Full Text] [Related]
35. SHP-2 regulates the phosphatidylinositide 3'-kinase/Akt pathway and suppresses caspase 3-mediated apoptosis.
Ivins Zito C; Kontaridis MI; Fornaro M; Feng GS; Bennett AM
J Cell Physiol; 2004 May; 199(2):227-36. PubMed ID: 15040005
[TBL] [Abstract][Full Text] [Related]
36. Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter.
Nyga R; Pecquet C; Harir N; Gu H; Dhennin-Duthille I; Régnier A; Gouilleux-Gruart V; Lassoued K; Gouilleux F
Biochem J; 2005 Aug; 390(Pt 1):359-66. PubMed ID: 15833084
[TBL] [Abstract][Full Text] [Related]
37. SHP-1 negatively regulates neuronal survival by functioning as a TrkA phosphatase.
Marsh HN; Dubreuil CI; Quevedo C; Lee A; Majdan M; Walsh GS; Hausdorff S; Said FA; Zoueva O; Kozlowski M; Siminovitch K; Neel BG; Miller FD; Kaplan DR
J Cell Biol; 2003 Dec; 163(5):999-1010. PubMed ID: 14662744
[TBL] [Abstract][Full Text] [Related]
38. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
[TBL] [Abstract][Full Text] [Related]
39. Gab2 is phosphorylated on tyrosine upon interleukin-2/interleukin-15 stimulation in mycosis-fungoides-derived tumor T cells and associates inducibly with SHP-2 and Stat5a.
Brockdorff JL; Gu H; Mustelin T; Kaltoft K; Geisler C; Röpke C; Ødum N
Exp Clin Immunogenet; 2001; 18(2):86-95. PubMed ID: 11340297
[TBL] [Abstract][Full Text] [Related]
40. A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail.
Poole AW; Jones ML
Cell Signal; 2005 Nov; 17(11):1323-32. PubMed ID: 16084691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
